Cancer Network spoke with Yoland Catherine Antill, MD, of Cabrini Health, about the phase II PHAEDRA trial, which tested the activity of durvalumab in advanced endometrial cancer according to mismatch repair status.
Yoland Catherine Antill, MD
Advertisement
Articles by Yoland Catherine Antill, MD
Advertisement
Latest Updated Articles
Dr. Yoland Catherine Antill on Results of the PHAEDRA TrialPublished: June 11th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer
3
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
4
How Can Lower-Income Countries Maintain Representation in Clinical Trials?
5
